Semler Scientific, Inc.
NASDAQ Capital MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Semler Scientific, Inc. engages in the development and commercialization of innovative diagnostic devices and healthcare solutions, primarily focusing on rapid, non-invasive point-of-care tests for vascular diseases and cardiac conditions including their flagship product QuantaFlo, which is used to detect peripheral arterial disease (PAD) via a proprietary sensor and software algorithm; the company also pursues expansion into early detection of heart failure and cardiac arrhythmia through its wholly owned subsidiary CardioVanta. Semler Scientific operates in the medical diagnostics and healthcare technology industry primarily within the United States and has strategically positioned itself as a dual-platform company by integrating a substantial Bitcoin treasury investment approach, holding over 5,000 bitcoins valued in the hundreds of millions, reflecting one of the largest public corporate Bitcoin holdings which diversifies its financial strategy. Founded in 2007 and headquartered in Englewood, Colorado, Semler Scientific recently entered an all-stock acquisition agreement with Strive, Inc., a bitcoin treasury and asset management company, in a transaction valued at approximately $1.34 billion that represents a 210% premium to the prior market price, marking a significant corporate strategic shift integrating medical technology with crypto asset management. Recent developments include ongoing FDA regulatory efforts to expand QuantaFlo's indications for cardiovascular disease diagnosis, efforts to resolve a $29.75 million settlement with the U.S. Department of Justice related to Medicare claims without admitting wrongdoing, and a major reduction in revenue projections linked to a key customer decreasing usage of the QuantaFlo device; the company has also been actively raising capital through various at-the-market equity offerings to support Bitcoin treasury expansions and innovation within its healthcare business. Semler Scientific combines its medical diagnostic expertise with innovative healthcare products and robust Bitcoin asset management to target healthcare providers, patients with vascular and cardiac risk factors, and investors in digital asset strategies.
Kuehn Law Encourages Investors of Semler Scientific to Contact Law Firm
Analysts Set Semler Scientific Inc. (NASDAQ:SMLR) Price Target at $74.25
Generali Asset Management SPA SGR Grows Stock Holdings in Semler Scientific Inc. $SMLR
Analysts Set Semler Scientific Inc. (NASDAQ:SMLR) PT at $74.25
Semler Scientific (NASDAQ:SMLR) & Vasamed (OTCMKTS:VSMD) Head-To-Head Survey
Semler Scientific Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Semler Scientific, Inc. - SMLR
Crypto's Hottest Trade Crumples
SMLR Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Merger of Semler Scientific With Strive Asset Management
Semler Scientific® to Release Third Quarter 2025 Financial Results
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 28, 2025 in Semler Scientific, Inc. Lawsuit – SMLR
Semler Scientific Deadline: SMLR Investors Have Opportunity to Lead Semler Scientific, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm
SMLR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Semler Scientific, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SMLR Deadline Today: Rosen Law Firm Encourages Semler Scientific, Inc. Investors to Secure Counsel Before Important October 28 Deadline in Securities Class Action First Filed by the Firm – SMLR
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Semler Scientific, Inc. of Class Action Lawsuit and Upcoming Deadlines - SMLR
SMLR FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Investors of the Semler Scientific Upcoming Lead Plaintiff Deadline on Tuesday, October 28, 2025
Semler Scientific, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 28, 2025 to Discuss Your Rights - SMLR
Strive: Strategic Expansion Meets Bitcoin Tailwinds -- Set For A Solid 2025 Finish
SEMLER FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Semler Stockholders to Contact the Firm Before October 28th
Portnoy Law Firm Announces Class Action on Behalf of Semler Scientific, Inc. Investors
Deadline Soon: Semler Scientific Inc. (SMLR) Shareholders Who Lost Money Urged to Contact the Law Offices of Frank R. Cruz About Securities Fraud Lawsuit